Section Arrow
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International plc
Quotes are at least 15-min delayed:2024/10/31 19:01 EDT
Last
 22.57
-0.44 (-1.91%)
Day High 
23.2 
Prev. Close
23.01 
1-M High
28.15 
Volume 
474.36K 
Bid
22.55
Ask
24.05
Day Low
22.34 
Open
22.87 
1-M Low
20.2552 
Market Cap 
1.64B 
Currency USD 
P/E 199.31 
%Yield -- 
10-SMA 26.08 
20-SMA 25.74 
50-SMA 25.57 
52-W High 28.15 
52-W Low 14.12 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.15/--
Enterprise Value
1.65B
Balance Sheet
Book Value Per Share
6.11
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
270.26M
Operating Revenue Per Share
3.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BFRIBiofrontera1.2203+0.2864+30.67%-- 
TLRYTilray Brands1.64-0.05-2.96%-- 
ELANElanco Animal Health12.64-0.14-1.10%-- 
VTRSViatris11.6-0.29-2.44%227.2PE
HLNHaleon plc9.69-0.11-1.12%32.05PE
Quotes are at least 15-min delayed:2024/10/31 19:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.